30.3.2021 – A Trail blazing company in a Munich suburb has come up with a cure for Covid 19. This is not a vaccine, but will actually cure the virus. and will work with all known variants. Every Corona 19 virus needs an ACE2 protein on the surface of the human cells of the nose, [...]
17.3.2021 – Today the European Commission is proposing to create a Digital Green Certificate to facilitate safe free movement inside the EU during the COVID-19 pandemic. The Digital Green Certificate will be a proof that a person has been vaccinated against COVID-19, received a negative test result or recovered from COVID-19. It will be available, [...]
4.3.2021 – The Commission sets out its ambition for a strong Social Europe that focuses on jobs and skills for the future and paves the way for a fair, inclusive and resilient socio-economic recovery. The European Pillar of Social Rights Action Plan outlines concrete actions to further implement the principles of the European Pillar of [...]
2.3.2021 – The European Commission published its annual report on the Safety Gate, which is the EU rapid alert system for dangerous consumer products helping to take dangerous non-food products off the market. The report shows that the number of actions taken by authorities following an alert is growing year by year, reaching a new [...]
17.2. 20121 – The Commission is proposing immediate action to prepare Europe for the increased threat of coronavirus variants. The new European bio-defence preparedness plan against COVID-19 variants called “HERA Incubator” will work with researchers, biotech companies, manufacturers and public authorities in the EU and globally to detect new variants, provide incentives to develop new [...]
10.2.2021 – The European Union is sending medical supplies, such as gloves, masks and overalls to Moldova, Montenegro, North Macedonia and Serbia following their requests for assistance through the EU Civil Protection Mechanism. The EU will draw on its rescEU medical reserve based in Greece to respond to the request of Montenegro and North Macedonia. [...]
12.1.2021 – European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses.Exploratory talks [...]
7.1.2021 – Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) [...]
21.12.2020 – Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the [...]
8.10.2020 -Today, the European Commission approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Once the vaccine has proven to be safe and effective against COVID-19, the contract allows Member States to purchase vaccines for 200 million people. They will also have the [...]
18.9.2020 – Today, a second contract with a pharmaceutical company entered into force following the contract’s formal signature between Sanofi-GSK and the Commission. The contract will allow all EU Member States to purchase up to 300 million doses of the Sanofi-GSK vaccine. Moreover, Member States may donate reserved doses to lower- and middle-income countries. Sanofi [...]
17.9.2020 – The EPP Group supports the use of €12 billion to help Europe’s cultural and creative sectors recover from the COVID-19 crisis. This money should be taken from the EU’s planned Recovery and Resilience Facility. “We call for clearly dedicated money to secure the jobs of almost 8 million artists and workers of the [...]
27.8.2020 – Today, the first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force following the formal signature between AstraZeneca and the Commission. The contract will allow the purchase of a vaccine against COVID-19 for all the Member States of the EU as well [...]
25.8.2020 – The European Commission has today concluded exploratory talks with Moderna to purchase a potential vaccine against COVID-19. Moderna is the fifth company with which the Commission has concluded talks, following Sanofi-GSK on 31 July, Johnson & Johnson on 13 August, CureVac on 18 August, in addition to the signature of an Advance Purchase [...]
29.7.2020 – Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in order to meet immediate needs, batches of Veklury will [...]